Your browser doesn't support javascript.
loading
Ultrashort Door-to-Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019.
Mikulík, Robert; Bar, Michal; Belasková, Silvie; Cerník, David; Fiksa, Jan; Herzig, Roman; Jura, René; Jurák, Lubomír; Klecka, Lukás; Neumann, Jirí; Ostrý, Svatopluk; Sanák, Daniel; Sevcík, Petr; Skoda, Ondrej; Srámek, Martin; Tomek, Ales; Václavík, Daniel.
Afiliación
  • Mikulík R; International Clinical Research Center and Department of Neurology St. Anne's University Hospital in Brno Czech Republic.
  • Bar M; Faculty of Medicine at Masaryk University Brno Czech Republic.
  • Belasková S; Department of Neurology University Hospital Ostrava and Faculty of Medicine at University Ostrava Ostrava Czech Republic.
  • Cerník D; International Clinical Research Center and Department of Neurology St. Anne's University Hospital in Brno Czech Republic.
  • Fiksa J; Comprehensive Stroke Center - Department of Neurology Masaryk Hospital Ustí nad Labem - KZ a.s. Ustí nad Labem Czech Republic.
  • Herzig R; Department of Neurology First Faculty of Medicine and General University Hospital, Charles University Prague Czech Republic.
  • Jura R; Comprehensive Stroke Center University Hospital Hradec KrálovéCharles University Faculty of Medicine in Hradec Králové Czech Republic.
  • Jurák L; Faculty of Medicine at Masaryk University Brno Czech Republic.
  • Klecka L; Department of Neurology University Hospital Brno Brno Czech Republic.
  • Neumann J; Neurocenter Regional Hospital Liberec Liberec Czech Republic.
  • Ostrý S; Department of Neurology Town Hospital Ostrava Ostrava Czech Republic.
  • Sanák D; Department of Neurology Chomutov Hospital, KZ a.s. Chomutov Czech Republic.
  • Sevcík P; Comprehensive Stroke Center Hospital Ceské Budejovice, a.s. Ceské Budejovice Czech Republic.
  • Skoda O; Department of Neurosurgery and Neurooncology First Faculty of Medicine Charles University in Prague Czech Republic.
  • Srámek M; Military University Hospital Prague Prague Czech Republic.
  • Tomek A; Comprehensive Stroke Center in Department of Neurology Palacký Medical School and University Hospital Olomouc Czech Republic.
  • Václavík D; Department of Neurology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic.
J Am Heart Assoc ; 11(10): e023524, 2022 05 17.
Article en En | MEDLINE | ID: mdl-35574953
ABSTRACT
Background The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door-to-needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. Methods and Results Multifaceted intervention to shorten DNT was introduced at a national level, and prospectively collected data from a registry between 2004 and 2019 were analyzed. Generalized estimating equation was used to identify the association between DNT and outcomes independently from prespecified baseline variables. The primary outcome was modified Rankin score 0 to 1 at 3 months, and secondary outcomes were parenchymal hemorrhage/intracerebral hemorrhage (ICH), any ICH, and death. Of 31 316 patients treated with intravenous thrombolysis alone, 18 861 (60%) had available data age 70±13 years, National Institutes of Health Stroke Scale at baseline (median, 8; interquartile range, 5-14), and 45% men. DNT groups 0 to 20 minutes, 21 to 40 minutes, 41 to 60 minutes, and >60 minutes had 3536 (19%), 5333 (28%), 4856 (26%), and 5136 (27%) patients. National median DNT dropped from 74 minutes in 2004 to 22 minutes in 2019. Shorter DNT had proportional benefit it increased the odds of achieving modified Rankin score 0 to 1 and decreased the odds of parenchymal hemorrhage/ICH, any ICH, and mortality. Patients with DNT ≤20 minutes, 21 to 40 minutes, and 41 to 60 minutes as compared with DNT >60 minutes had adjusted odds ratios for modified Rankin score 0 to 1 of the following 1.30 (95% CI, 1.12-1.51), 1.33 (95% CI, 1.15-1.54), and 1.15 (95% CI, 1.02-1.29), and for parenchymal hemorrhage/ICH 0.57 (95% CI, 0.45-0.71), 0.76 (95% CI, 0.61-0.94), 0.83 (95% CI, 0.70-0.99), respectively. Conclusions Ultrashort initiation of thrombolysis is feasible, improves outcome, and makes treatments safer because of fewer intracerebral hemorrhages. Stroke management should be optimized to initiate thrombolysis as soon as possible optimally within 20 minutes from arrival to a hospital.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Heart Assoc Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Heart Assoc Año: 2022 Tipo del documento: Article
...